The Medicare Prescription Payment Plan can make drug cost more predictable for your Part D patients

The Inflation Reduction Act (IRA) will continue to help Medicare Part D patients manage their out-of-pocket (OOP) drug costs in 2026
• A $2,100 cap is set on total annual OOP drug spending for Part D beneficiaries1
• The Medicare Prescription Payment Plan lets Part D beneficiaries spread out their OOP drug costs into monthly payments throughout the year2

Format: PDF (2 pages)

Presented by Regeneron

Posted 4/2026